Industry Symposia
Friday, November 6, 2015 11:40-13:10 Novo Nordisk Satellite Symposium: Roshni Kulkarni, USA Monitoring hemophilia treatment: Assays for the assessment of novel replacement factors Relationship between factor activity and joint bleeding in patients with mild or moderate hemophilia Management of Glanzmann’s thrombasthenia and other congenital rare bleeding disorders in women: A Gulf country perspective
Hall A
11:40-13:10
Hemophilia and other congenital rare bleeding disorders: From laboratory assessment to clinical management
Chairpersons:
Snejana Krassova, Switzerland
11:40
Introduction and objectives
Snejana Krassova, Switzerland
11:45
Paul Giangrande, UK
12:05
Assessment of outcomes in hemophilia: Benefits and limitations of post-marketing studies
Soraya Benchikh El Fegoun,Switzerland
12:20
Roshni Kulkarni, USA
12:40
Ahmad M. Tarawah, Saudi Arabia
13:00
Discussion
Roshni Kulkarni, USA
Snejana Krassova, Switzerland